Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering
October 28, 2019 09:21 ET
|
Guardion Health Sciences, Inc.
San Diego, CA, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced the pricing of an underwritten public offering of 24,500,000...
Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF
October 23, 2019 07:00 ET
|
Guardion Health Sciences, Inc.
San Diego, California, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced that it has received approval from the USPTO for...
Guardion® Announces Statistically Significant Blood Assay Study Results
October 10, 2019 10:30 ET
|
Guardion Health Sciences, Inc.
Study Results Show 40 Times Higher Blood Concentration Levels of Mesozeaxanthin From Lumega-Z, Guardion’s Flagship Medical Food, as compared to Standard AREDS2 Over-The-Counter Gel Caps San Diego,...
Guardion Health Sciences Acquires the NutriGuard Brand of Products
September 23, 2019 10:30 ET
|
Guardion Health Sciences, Inc.
San Diego, California, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI), through its newly-formed wholly-owned subsidiary, NutriGuard...
Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity Test
September 03, 2019 07:00 ET
|
Guardion Health Sciences, Inc.
New Generation of Vision Testing Technology to be Introduced at Vision Expo West San Diego, CA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”)...
Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering
August 15, 2019 16:05 ET
|
Guardion Health Sciences, Inc.
San Diego, CA , Aug. 15, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously announced underwritten...
Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering
August 15, 2019 08:35 ET
|
Guardion Health Sciences, Inc.
San Diego, CA, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), previously announced the pricing of an underwritten public offering of...
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering
August 13, 2019 09:00 ET
|
Guardion Health Sciences, Inc.
San Diego, CA, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced the pricing of an underwritten public offering of 13,000,000...
Guardion Health Sciences Reports June 30, 2019 Interim Results of Operations
August 12, 2019 08:40 ET
|
Guardion Health Sciences, Inc.
Highlights Include: 18.2% Revenue Growth for the Three Months Ended June 30, 2019 and 21.7% Revenue Growth for the Six Months Ended June 30, 2019 San Diego, CA , Aug. 12, 2019 (GLOBE...
Foundation Fighting Blindness selects Guardion’s VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-Center Clinical Trial
August 06, 2019 07:00 ET
|
Guardion Health Sciences, Inc.
The CSV-1000 Diagnostic Instrument is Considered the Standard of Care for the Measurement of Contrast Sensitivity San Diego, CA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc....